Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

642 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Leaving behind a diseased small bowel during surgery for Crohn's disease: Long-term outcomes.
Angriman I, Degasperi S, Mescoli C, Lacognata C, Armellin C, Caruso A, Scognamiglio F, Fassan M, D'Incà R, Savarino E, Zingone F, Spolverato G, Pucciarelli S, Bardini R, Ruffolo C, Scarpa M. Angriman I, et al. Among authors: savarino e. Surg Today. 2024 Jun;54(6):523-533. doi: 10.1007/s00595-023-02759-w. Epub 2023 Oct 26. Surg Today. 2024. PMID: 37882838
Personalize, participate, predict, and prevent: 4Ps in inflammatory bowel disease.
Lenti MV, Scribano ML, Biancone L, Ciccocioppo R, Pugliese D, Pastorelli L, Fiorino G, Savarino E, Caprioli FA, Ardizzone S, Fantini MC, Tontini GE, Orlando A, Sampietro GM, Sturniolo GC, Monteleone G, Vecchi M, Kohn A, Daperno M, D'Incà R, Corazza GR, Di Sabatino A. Lenti MV, et al. Among authors: savarino e. Front Med (Lausanne). 2023 Apr 11;10:1031998. doi: 10.3389/fmed.2023.1031998. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37113615 Free PMC article. Review.
Use of tofacitinib as first or second-line therapy is associated with better outcomes in patients with ulcerative colitis: data from a real-world study.
Tursi A, Mocci G, Cingolani L, Savarino E, Pica R, Cocco A, Zippi M, Napolitano D, Schiavoni E, Pugliese D, Scaldaferri F, Costa F, Marzo M, Serio M, Scarcelli A, Bolognini L, Bendia E, Maconi G, Cannatelli R, Piergallini S, Bodini G, Calabrese F, Ferronato A, Pranzo G, Elisei W, Monterubbianesi R, Faggiani R, Rodinò S, Sebkova L, Grossi L, Gaiani F, Dè Angelis G, Lorenzetti R, Allegretta L, Cazzato AI, Scorza S, Della Valle N, Sacco R, Forti G, Colucci R, Tonti P, Neve V, Rocco G, Sacchi C, Zampaletta C, Pagnini C, Graziani MG, Di Paolo MC, Onidi FM, Usai Satta P, Picchio M, Papa A. Tursi A, et al. Among authors: savarino e. Expert Opin Pharmacother. 2023 Sep-Dec;24(14):1649-1656. doi: 10.1080/14656566.2023.2230126. Epub 2023 Jun 28. Expert Opin Pharmacother. 2023. PMID: 37358928
Results of the Eighth Scientific Workshop of ECCO: Diagnosing Postoperative Recurrence of Crohn's Disease After an Ileocolonic Resection With Ileocolonic Anastomosis.
Dragoni G, Allocca M, Myrelid P, Noor NM, Hammoudi N; Eighth Scientific Workshop of the European Crohn’s and Colitis Organisation; Rivière P, Panis Y, Ferrante M. Dragoni G, et al. J Crohns Colitis. 2023 Oct 20;17(9):1373-1386. doi: 10.1093/ecco-jcc/jjad055. J Crohns Colitis. 2023. PMID: 37070339
Vedolizumab for the Treatment of Chronic Pouchitis.
Travis S, Silverberg MS, Danese S, Gionchetti P, Löwenberg M, Jairath V, Feagan BG, Bressler B, Ferrante M, Hart A, Lindner D, Escher A, Jones S, Shen B; EARNEST Study Group. Travis S, et al. N Engl J Med. 2023 Mar 30;388(13):1191-1200. doi: 10.1056/NEJMoa2208450. N Engl J Med. 2023. PMID: 36988594 Clinical Trial.
Management of Patients With Refractory Reflux-Like Symptoms Despite Proton Pump Inhibitor Therapy: Evidence-Based Consensus Statements.
Armstrong D, Hungin AP, Kahrilas PJ, Sifrim D, Moayyedi P, Vaezi MF, Al-Awadhi S, Anvari S, Bell R, Delaney B, Emura F, Gyawali CP, Katelaris P, Lazarescu A, Lee YY, Repici A, Roman S, Rooker CT, Savarino EV, Sinclair P, Sugano K, Yadlapati R, Yuan Y, Zerbib F, Sharma P; International Working Group for the Classification of Oesophagitis (IWGCO). Armstrong D, et al. Among authors: savarino ev. Aliment Pharmacol Ther. 2024 Dec 30. doi: 10.1111/apt.18420. Online ahead of print. Aliment Pharmacol Ther. 2024. PMID: 39740235
European clinical practice guideline: managing and treating laryngopharyngeal reflux disease.
Lechien JR, Chiesa-Estomba CM, Hans S, Nacci A, Schindler A, Bohlender JE, Runggaldier D, Crevier-Buchman L, Oguz H, Zelenik K, Tedla M, Siupsinskiene N, Schlömicher-Thier J, Taimrova R, Karkos PD, Geneid A, Dapri G, Aoun J, Muls V, Weitzendorfer M, Savarino EV, Remacle MJ, Sereg-Bahar M, Mayo-Yanez M, Iannella G, Saibene AM, Vaira LA, Cammaroto G, Maniaci A, Barillari MR. Lechien JR, et al. Among authors: savarino ev. Eur Arch Otorhinolaryngol. 2024 Dec 24. doi: 10.1007/s00405-024-09181-z. Online ahead of print. Eur Arch Otorhinolaryngol. 2024. PMID: 39719472
Advancing therapeutic frontiers: a pipeline of novel drugs for luminal and perianal Crohn's disease management.
Bertin L, Crepaldi M, Zanconato M, Lorenzon G, Maniero D, de Barba C, Bonazzi E, Facchin S, Scarpa M, Ruffolo C, Angriman I, Buda A, Zingone F, Barberio B, Savarino EV. Bertin L, et al. Among authors: savarino ev. Therap Adv Gastroenterol. 2024 Dec 19;17:17562848241303651. doi: 10.1177/17562848241303651. eCollection 2024. Therap Adv Gastroenterol. 2024. PMID: 39711916 Free PMC article. Review.
642 results